CORALLINI, Federica
 Distribuzione geografica
Continente #
NA - Nord America 4.548
AS - Asia 2.050
EU - Europa 911
SA - Sud America 271
AF - Africa 52
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.840
Nazione #
US - Stati Uniti d'America 4.480
SG - Singapore 784
CN - Cina 591
VN - Vietnam 226
BR - Brasile 216
UA - Ucraina 190
DE - Germania 161
GB - Regno Unito 145
HK - Hong Kong 134
IT - Italia 133
TR - Turchia 127
FI - Finlandia 62
FR - Francia 59
CA - Canada 42
SE - Svezia 40
RU - Federazione Russa 37
IN - India 36
ZA - Sudafrica 27
JP - Giappone 24
PL - Polonia 24
BD - Bangladesh 23
AR - Argentina 22
IQ - Iraq 19
PK - Pakistan 18
MX - Messico 17
CZ - Repubblica Ceca 11
ID - Indonesia 11
CO - Colombia 10
ES - Italia 10
EC - Ecuador 9
NL - Olanda 9
AE - Emirati Arabi Uniti 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
VE - Venezuela 7
AU - Australia 6
EG - Egitto 6
LT - Lituania 6
MA - Marocco 6
BE - Belgio 5
IR - Iran 5
MY - Malesia 5
CL - Cile 4
IL - Israele 4
PH - Filippine 4
RO - Romania 4
DZ - Algeria 3
HR - Croazia 3
JM - Giamaica 3
KE - Kenya 3
KG - Kirghizistan 3
NP - Nepal 3
IE - Irlanda 2
JO - Giordania 2
KR - Corea 2
LY - Libia 2
MD - Moldavia 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
TH - Thailandia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GP - Guadalupe 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TG - Togo 1
TN - Tunisia 1
TW - Taiwan 1
Totale 7.840
Città #
Fairfield 505
Ashburn 480
Woodbridge 470
Singapore 447
Houston 270
Seattle 223
Ann Arbor 221
Chandler 211
Jacksonville 210
San Jose 205
Cambridge 183
Beijing 169
Wilmington 166
Santa Clara 156
Hong Kong 132
Los Angeles 86
Ho Chi Minh City 83
New York 83
Dallas 79
Nanjing 69
Izmir 66
Hanoi 50
Princeton 47
Lauterbourg 36
Munich 36
San Diego 36
Boardman 34
Milan 31
Shanghai 26
Shenyang 25
São Paulo 24
Nanchang 23
Tokyo 23
Buffalo 22
Ferrara 21
Orem 20
Warsaw 20
Johannesburg 17
Montreal 15
The Dalles 15
Tianjin 15
Changsha 14
London 14
Council Bluffs 13
Da Nang 13
Falls Church 13
Jinan 13
San Mateo 13
Chennai 12
Poplar 12
Turku 12
Auburn Hills 11
Chicago 11
Frankfurt am Main 11
Haiphong 11
Hebei 11
Mexico City 11
Mountain View 11
Zhengzhou 11
San Francisco 10
Dearborn 9
Hefei 9
Stockholm 9
Atlanta 8
Falkenstein 8
Helsinki 8
Manchester 8
Baghdad 7
Bremen 7
Brno 7
Moscow 7
Philadelphia 7
Rome 7
Toronto 7
Boston 6
Brasília 6
Brooklyn 6
Columbus 6
Guangzhou 6
Haikou 6
Ottawa 6
Phoenix 6
Redwood City 6
Rio de Janeiro 6
Amsterdam 5
Brussels 5
Bắc Ninh 5
Charlotte 5
Curitiba 5
Denver 5
Guarulhos 5
Istanbul 5
Jakarta 5
Kunming 5
Norwalk 5
Paris 5
Porto Alegre 5
Tappahannock 5
Tashkent 5
Vancouver 5
Totale 5.525
Nome #
Antiangiogenic activity of the MDM2 antagonist nutlin-3 248
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 247
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye 246
Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults 237
Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies 225
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 223
Anti-leukemic activity of Dasatinib in both p53 wild-type and p53 mutated B malignant cells 221
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts 215
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 214
Is there any role for tumour necrosis factor related apoptosis inducing ligand–osteoprotegerin (TRAIL–OPG) interaction in rheumatoid arthritis? 206
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release 205
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 202
Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin 201
Circulating levels of frizzled-related protein (FRZB) are increased in patients with early rheumatoid arthritis and decrease in response to disease-modifying antirheumatic drugs. 200
Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts 188
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 187
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 182
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors 181
Potential role of PKC inhibitors in the treatment of hematological malignancies 180
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. 178
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells 175
The tumour necrosis factor-related apoptosis inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker? 168
TRAIL and osteoprotegerin: a role in endothelial physiopathology? 162
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 161
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 160
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction 155
TRAIL, caspases and maturation of normal and leukemic myeloid precursors 152
Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction 151
An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction 146
TNFRSF11B (tumor necrosis factor receptor superfamily, member 11b) 145
The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis 140
Metalloproteinase 2 cleaves in vitro recombinant TRAIL: Potential implications for the decreased serum levels of TRAIL after acute myocardial infarction 136
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 133
Ruolo di trail nella patogenesi del danno neuronale indotto dalla proteina Tat di HIV-1 120
Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand 120
Baseline serum concentrations of TRAIL in early rheumatoid arthritis: Relationship with response to disease-modifying antirheumatic drugs 112
TNF-α modulates the migratory response of mesenchymal stem cells to TRAIL 108
Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo 107
null 102
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro 100
null 97
null 94
null 90
null 89
null 88
null 86
null 78
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo 75
null 74
null 65
Selective induction of TP53I3/p53-inducible gene 3 (PIG3) in myeloid leukemic cells, but not in normal cells, by Nutlin-3 57
The potential role of Nutlins in the treatment of B-chronic lymphocytic leukemia (B-CLL) 45
Totale 7.877
Categoria #
all - tutte 31.472
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.472


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021173 0 0 0 0 0 0 0 0 0 68 75 30
2021/2022522 15 57 56 11 15 26 35 25 14 29 66 173
2022/2023457 40 23 17 49 80 78 25 40 47 7 28 23
2023/2024197 16 26 3 5 11 51 9 13 1 3 3 56
2024/2025988 21 32 66 50 144 72 23 47 216 75 143 99
2025/20262.555 281 99 287 344 394 189 329 118 259 255 0 0
Totale 7.877